Schonfeld Strategic Advisors LLC lifted its position in Ambev S.A. (NYSE:ABEV - Free Report) by 1,313.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 268,500 shares of the company's stock after purchasing an additional 249,500 shares during the period. Schonfeld Strategic Advisors LLC's holdings in Ambev were worth $497,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds have also recently added to or reduced their stakes in the company. GQG Partners LLC raised its position in Ambev by 51.9% during the fourth quarter. GQG Partners LLC now owns 196,676,003 shares of the company's stock worth $363,851,000 after acquiring an additional 67,180,274 shares during the period. Arrowstreet Capital Limited Partnership lifted its stake in Ambev by 1,641.9% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 19,001,985 shares of the company's stock valued at $35,154,000 after buying an additional 17,911,122 shares in the last quarter. Brandywine Global Investment Management LLC boosted its holdings in Ambev by 5.0% in the 4th quarter. Brandywine Global Investment Management LLC now owns 18,614,210 shares of the company's stock worth $34,436,000 after buying an additional 880,763 shares during the last quarter. Allspring Global Investments Holdings LLC increased its stake in Ambev by 39.9% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 18,519,980 shares of the company's stock worth $33,892,000 after buying an additional 5,283,746 shares in the last quarter. Finally, CANADA LIFE ASSURANCE Co raised its holdings in shares of Ambev by 101.1% during the fourth quarter. CANADA LIFE ASSURANCE Co now owns 15,639,612 shares of the company's stock valued at $29,512,000 after acquiring an additional 7,862,672 shares during the last quarter. 8.13% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several brokerages recently commented on ABEV. StockNews.com initiated coverage on Ambev in a research report on Wednesday, April 23rd. They set a "buy" rating for the company. Morgan Stanley downgraded shares of Ambev from an "equal weight" rating to an "underweight" rating in a research note on Monday, April 7th. UBS Group cut shares of Ambev from a "buy" rating to a "neutral" rating in a research note on Tuesday, April 22nd. Barclays lowered their target price on Ambev from $2.50 to $2.00 and set an "equal weight" rating on the stock in a report on Tuesday, January 21st. Finally, Bank of America cut Ambev from a "buy" rating to a "neutral" rating in a report on Friday, January 17th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $2.45.
Read Our Latest Research Report on ABEV
Ambev Price Performance
Shares of NYSE ABEV opened at $2.53 on Friday. The company has a market capitalization of $39.87 billion, a P/E ratio of 14.06, a P/E/G ratio of 5.80 and a beta of 0.80. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.20 and a quick ratio of 0.89. The company has a 50 day simple moving average of $2.35 and a 200-day simple moving average of $2.13. Ambev S.A. has a 1 year low of $1.76 and a 1 year high of $2.64.
Ambev (NYSE:ABEV - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $0.04 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.04. The company had revenue of $3.92 billion during the quarter, compared to analysts' expectations of $22.40 billion. Ambev had a return on equity of 16.12% and a net margin of 17.02%. On average, equities research analysts predict that Ambev S.A. will post 0.18 earnings per share for the current year.
Ambev Cuts Dividend
The business also recently announced a quarterly dividend, which was paid on Monday, April 14th. Shareholders of record on Tuesday, March 18th were paid a dividend of $0.0221 per share. This represents a $0.09 annualized dividend and a yield of 3.49%. The ex-dividend date of this dividend was Tuesday, March 18th. Ambev's dividend payout ratio (DPR) is presently 52.94%.
Ambev Profile
(
Free Report)
Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt and food, other alcoholic beverages, and non-alcoholic and non-carbonated products in Brazil, Central America and Caribbean, Latin America South, and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe, Hoegaarden, Balboa ICE, Balboa, Atlas Golden Light, Atlas, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Bud 66, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.
Read More
Want to see what other hedge funds are holding ABEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ambev S.A. (NYSE:ABEV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ambev, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambev wasn't on the list.
While Ambev currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report